GLPwatch

Glucagon-like peptide-1 receptors within the nucleus of the solitary tract regulate alcohol-mediated behaviors in rodents.

Neuropharmacology · 2019

Last updated 2026-05-28

In mice, activating GLP-1 receptors in a brain region called the nucleus of the solitary tract (NTS) with a drug called exendin-4 (Ex4) reduced alcohol’s effects, including alcohol-induced movement, dopamine release in the brain’s reward area, and memory of alcohol reward. In rats that had been drinking alcohol for 12 weeks, Ex4 delivered directly to the NTS also decreased alcohol intake in a dose-dependent way. Blocking these receptors in the NTS prevented Ex4 from reducing alcohol’s stimulating effects in mice.

AI summary of the abstract below.

JournalNeuropharmacology, 2019
Citations50
Relative citation ratio2.66
NIH percentile81
Molecules
Conditions studied Alcohol Use Disorder

Abstract

The ability of glucagon-like peptide-1 (GLP-1) to reduce food intake involves activation of GLP-1 receptors (GLP-1R) in the nucleus of the solitary tract (NTS). It has also been demonstrated that systemic administration of GLP-1R agonists attenuates alcohol-mediated behaviors via, to date, unknown mechanisms. Therefore, we evaluated the effects of NTS-GLP-1R activation by exendin-4 (Ex4) on alcohol-induced locomotor stimulation, accumbal dopamine release and memory of alcohol reward in the conditioned place preference (CPP) model in mice. Moreover, the ability of Ex4 infusion into the NTS on alcohol intake was explored in rats. Ex4 into the NTS inhibits the acute effects of alcohol as measured by alcohol-induced locomotor stimulation, accumbal dopamine release and the memory consolidation of alcohol reward in the CPP paradigm. In addition, NTS-Ex4 dose-dependently decreases alcohol intake in rats consuming alcohol for 12 weeks. Pharmacological suppression of GLP-1R in the NTS prevents the ability of systemic Ex4 to block the alcohol-induced locomotor stimulation in mice. These data add a functional role of GLP-1R within the NTS, involving alcohol-related behaviors. In addition, they may provide insight into the GLP-1R containing brain areas that modulate the ability of GLP-1R agonists to reduce alcohol reinforcement. Collectively, this further supports GLP-1R as potential treatment targets for alcohol use disorder.

Verbatim abstract via PubMed 30772374 ↗